Enzene Biosciences Ltd

Enzene Biosciences Ltd company information, Employees & Contact Information

Enzene an integrated global CDMO offers services spanning discovery, development and commercial supply. Its patented fully-connected continuous manufacturing (FCCM) platform, EnzeneX™, is validated for commercial biologics supply, and demonstrates significantly increased production yields and reduced costs. Enzene aims to lower mAb production costs below $40/gram by 2025. Visit www.enzene.com.
Looking for a particular Enzene Biosciences Ltd employee's phone or email?

Enzene Biosciences Ltd Questions

News

Enzene First in India for Virtuosi® - PR Newswire

Enzene First in India for Virtuosi® PR Newswire

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences - ABP Live English

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences ABP Live English

Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care - TheWire.in

Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care TheWire.in

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences - Mid-day

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences Mid-day

Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India - UNITED NEWS OF INDIA

Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India UNITED NEWS OF INDIA

Enzene Opens First U.S. Biomanufacturing Facility on Former BMS Campus in Hopewell - MercerMe

Enzene Opens First U.S. Biomanufacturing Facility on Former BMS Campus in Hopewell MercerMe

Enzene Biosciences forays into the US with new $50m Hopewell facility - Investment Monitor

Enzene Biosciences forays into the US with new $50m Hopewell facility Investment Monitor

Enzene’s $50M biopharma plant expands NJ’s life sciences sector - NJBIZ

Enzene’s $50M biopharma plant expands NJ’s life sciences sector NJBIZ

Enzene cuts ribbon on $50m New Jersey biologics facility - BioProcess International

Enzene cuts ribbon on $50m New Jersey biologics facility BioProcess International

India’s Enzene Opens $50M Bio-Pharma Manufacturing Plant in Hopewell - New Jersey Business Magazine

India’s Enzene Opens $50M Bio-Pharma Manufacturing Plant in Hopewell New Jersey Business Magazine

Veranova, Enzene plot new biologic manufacturing expansions on East Coast - Fierce Pharma

Veranova, Enzene plot new biologic manufacturing expansions on East Coast Fierce Pharma

Enzene Announces Commercial Supply of Pertuzumab - Contract Pharma

Enzene Announces Commercial Supply of Pertuzumab Contract Pharma

Enzene Biosciences Plans Biopharma Campus in USA - CHEManager

Enzene Biosciences Plans Biopharma Campus in USA CHEManager

Cyberattack compromises Enzene Biosciences’ funds - SC Media

Cyberattack compromises Enzene Biosciences’ funds SC Media

Increasing Access Through Continuous Biomanufacturing - BioProcess International

Increasing Access Through Continuous Biomanufacturing BioProcess International

Enzene Biosciences Ltd. obtains Marketing Authorization for its Romiplostim Biosimilar drug in India - PR Newswire

Enzene Biosciences Ltd. obtains Marketing Authorization for its Romiplostim Biosimilar drug in India PR Newswire

India's Enzene Biosciences unveils $50M New Jersey plant project, plans to hire 300 - Fierce Pharma

India's Enzene Biosciences unveils $50M New Jersey plant project, plans to hire 300 Fierce Pharma

India’s Enzene Biosciences to Open a $50M Bio-Manufacturing Plant in Hopewell - New Jersey Business Magazine

India’s Enzene Biosciences to Open a $50M Bio-Manufacturing Plant in Hopewell New Jersey Business Magazine

Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost - PR Newswire

Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost PR Newswire

Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India - PR Newswire

Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India PR Newswire

Enzene Biosciences Ltd. obtains Marketing Authorization for its first Biosimilar molecule in India - PR Newswire

Enzene Biosciences Ltd. obtains Marketing Authorization for its first Biosimilar molecule in India PR Newswire

Enzene takes first step out of India with NJ plant - BioProcess International

Enzene takes first step out of India with NJ plant BioProcess International

Alkem’s Enzene Biosciences Hit by Cyberattack, Funds Fraudulently Transferred - The Cyber Express

Alkem’s Enzene Biosciences Hit by Cyberattack, Funds Fraudulently Transferred The Cyber Express

Enzyme Engineering Market Size, Report by 2034 - Precedence Research

Enzyme Engineering Market Size, Report by 2034 Precedence Research

Enzene Biosciences Chooses Novasep BioSC® Pilot Chromatography for Its Automated End to End Continuous Manufacture of mAb - PR Newswire

Enzene Biosciences Chooses Novasep BioSC® Pilot Chromatography for Its Automated End to End Continuous Manufacture of mAb PR Newswire

Enzene Biosciences launches manufacturing base in US - financialexpress.com

Enzene Biosciences launches manufacturing base in US financialexpress.com

Enzene Biosciences launches biosimilar as rheumatoid arthritis medication - Healthcare Radius

Enzene Biosciences launches biosimilar as rheumatoid arthritis medication Healthcare Radius

Enzene Biosciences raises $50 million, aims to expand into global markets - Business Standard

Enzene Biosciences raises $50 million, aims to expand into global markets Business Standard

Enzene Biosciences launches Bevacizumab - Express Pharma

Enzene Biosciences launches Bevacizumab Express Pharma

Enzene Biosciences partners with Virtuosi - IndiaMedToday

Enzene Biosciences partners with Virtuosi IndiaMedToday

Enzene inaugurates its cutting-edge R&D facility in Pune - ET HealthWorld

Enzene inaugurates its cutting-edge R&D facility in Pune ET HealthWorld

Top Enzene Biosciences Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant